Home > Pill Identifier > Dimenhydrinate 50 MG Oral Tablet

Pill Identifier Information of Dimenhydrinate 50 MG Oral Tablet

Drug Information

Dimenhydrinate 50 MG Oral Tablet

Imprint: 44;198
Shape: C48348
Color: C48325
Ingredients: Dimenhydrinate
Size: 11.00
Score: 2
Rxtty: SCD
Author: Major Pharmaceuticals
Inactive Ingredients: CROSCARMELLOSE SODIUM / ANHYDROUS DIBASIC CALCIUM PHOSPHATE / MAGNESIUM STEARATE / CELLULOSE, MICROCRYSTALLINE / STEARIC ACID>

Complete Information

  • Warnings

    Do not use

    for children under 2 years of age unless directed by a doctor.

    Ask a doctor before use if you have
    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • difficulty in urination due to enlargement of the prostate gland 

    Ask a doctor or pharmacist before use if you are

    taking sedatives or tranquilizers.

    When using this product
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • marked drowsiness may occur
    • use caution when driving a motor vehicle or operating machinery
    • avoid alcoholic beverages

    • If pregnant or breast-feeding,

    ask a health professional before use. 

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not take more than directed
    • to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
    • to prevent or treat motion sickness, see below:
    adults and children 12 years and overâ–  take 1 to 2 tablets every 4-6 hours
    â–  do not take more than 8 tablets in 24 hours, or as directed by a doctor
    children 6 to under 12 yearsâ–  give 1/2 to 1 tablet every 6-8 hours
    â–  do not give more than 3 tablets in 24 hours, or as directed by a doctor
    children 2 to under 6 yearsâ–  give 1/2 tablet every 6-8 hours
    â–  do not give more than 1 1/2 tablets in 24 hours, or as directed by a doctor
  • Other information

    • each tablet contains: calcium 35 mg
    • protect from moisture
    • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
    • see end flap for expiration date and lot number
  • Inactive ingredients

    croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid 

  • Questions or comments?

    1-800-426-9391

  • Principal Display Panel

    MAJOR®

    NDC 0904-2051-59

    compare to the active ingredient in
    Dramamine® Original Formula*

    Driminateâ„¢

    dimenhydrinate 50 mg
    antiemetic

    for nausea, dizziness and vomiting from motion sickness

    100 tablets

    dye-free

    actual size 

    TAMPER EVIDENT: DO NOT USE IF
    IMPRINTED SAFETY SEAL UNDER
    CAP IS BROKEN OR MISSING

    Rev. 04/26 M-17 Re-order No. 700621

    *This product is not manufactured or distributed
    by Medtech Products Inc., owner of the
    registered trademark Dramamine® Original
    Formula.

    50844      REV0226Q19812

    Distributed by:
    MAJOR® PHARMACEUTICALS
    Indianapolis, IN 46268
    (800) 616-2471
    www.major-rugby.com

    Major 44 -198 REV0226Q

    Major 44 -198 REV0226Q

  • INGREDIENTS AND APPEARANCE
    DRIMINATE 
    dimenhydrinate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-2051
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE50 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeROUNDSize9mm
    FlavorImprint Code 44;198
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0904-2051-591 in 1 CARTON12/01/1992
    1100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    2NDC:0904-2051-122 in 1 CARTON12/01/1992
    26 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00912/01/1992
    Labeler - Major Pharmaceuticals (191427277)
    Establishment
    NameAddressID/FEIBusiness Operations
    LNK International, Inc.038154464pack(0904-2051)
    Establishment
    NameAddressID/FEIBusiness Operations
    LNK International, Inc.832867837manufacture(0904-2051) , pack(0904-2051)
    Establishment
    NameAddressID/FEIBusiness Operations
    LNK International, Inc.117025878manufacture(0904-2051)